Transformation Capital is a digital health growth equity firm dedicated to supporting commercial stage companies focused on improving people’s health and the sustainability of the healthcare system. The firm was founded on the premise that investing in healthcare requires both a sophisticated understanding of the healthcare system, including the prevailing market forces and resulting opportunities, as well as deep connections with decision makers across key providers, payers and digital health innovators. Transformation Capital has invested in digital health companies across the ecosystem, including Datavant, Apree, Capital RX, Health Catalyst, Sword, Grow, Jeenie and Groups.